RECRUITING
I'm interested ...!!
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.
Conditions:
🦠 Interstitial Lung Diseases 🦠 Idiopathic Pulmonary Fibrosis 🦠 Sarcoidosis 🦠 Connective Tissue Disorder
🗓️ Study Start (Actual) September 2005
🗓️ Primary Completion (Estimated) December 2025
✅ Study Completion (Estimated) December 2025
👥 Enrollment (Estimated) 4000
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Chicago, Illinois, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Interstitial lung disease

    Exclusion Criteria:

    • * Does not have Interstitial lung disease
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 3 May 2007
  • First Submitted that Met QC Criteria 4 May 2007
  • First Posted 7 May 2007

Study Record Updates

  • Last Update Submitted that Met QC Criteria 29 November 2023
  • Last Update Posted 30 November 2023
  • Last Verified November 2023
I'm interested ...!!